The updated, revised Second Edition of this book is more than twice the size, twice as enjoyable, and, given today's pharmacopolitical climate, twice as relevant as its predecessor. Enhanced by many more real-world examples, more up-to-date tables and charts, and revamped drawings and schematics, Multinational Pharmaceutical Companies features new, 90s-oriented chapters on costs and pricing, animal research, pharmacopolitics, prescription to over-the-counter conversions, mergers and joint ventures, licensing, patents, biotechnology, and legal issues. An entirely new section on the medical-marketing interface covers corporate issues, organizational and staffing issues, and joint medical and marketing activities, and discusses medical and marketing needs, wants, possibilities, and problems in developing new drugs. Chapters on marketing, production, finance, technical development, and portfolio analysis have been significantly expanded. This new book also includes more of Spilker's "golden rules" of drug discovery and development
Le informazioni nella sezione "Riassunto" possono far riferimento a edizioni diverse di questo titolo.
EUR 24,00 per la spedizione da Germania a U.S.A.
Destinazione, tempi e costiEUR 3,83 per la spedizione in U.S.A.
Destinazione, tempi e costiDa: NEPO UG, Rüsselsheim am Main, Germania
Gebundene Ausgabe. Condizione: Sehr gut. 803 Seiten Sprache: Englisch Gewicht in Gramm: 2250. Codice articolo 245861
Quantità: 1 disponibili
Da: Toscana Books, AUSTIN, TX, U.S.A.
Hardcover. Condizione: new. Excellent Condition.Excels in customer satisfaction, prompt replies, and quality checks. Codice articolo Scanned0781701007
Quantità: 1 disponibili